Chief Ethics, Risk and Compliance Officer for Novartis
Nationality: American Year of Birth: 1971
Shannon Thyme Klinger was appointed Chief Ethics, Risk and Compliance Officer for Novartis on April 1, 2018. She is a member of the Executive Committee of Novartis.
Ms. Klinger most recently served as Chief Ethics and Compliance Officer and Head of Litigation for Novartis. She joined Novartis in 2011 as General Counsel, North America, for Sandoz in the United States and later became the Global Head of Legal and General Counsel for Sandoz International GmbH. Prior to Novartis, Ms. Klinger worked in the US as a partner at Mayer Brown LLP from 2010 to 2011, senior vice president and general counsel for Solvay Pharmaceuticals Inc. from 2008 to 2010, and vice president of marketing compliance and associate counsel for Barr Laboratories/Duramed Pharmaceuticals from 2005 to 2007. Before that, she was a partner at Alston & Bird LLP in the US, where she focused on False Claims Act litigation and antitrust, pharmaceutical legal and regulatory matters.
Ms. Klinger holds a juris doctor with honors from the University of North Carolina at Chapel Hill and a bachelor’s degree in psychology from the University of Notre Dame (both in the US). She is a member of the board of directors of the SIX Group.